Sabra Health Care REIT Files Q1 2024 10-Q

Ticker: SBRA · Form: 10-Q · Filed: 2024-05-08T00:00:00.000Z

Sentiment: neutral

Topics: real-estate, REIT, financials, 10-Q

TL;DR

**Sabra Health Care REIT Q1 2024 10-Q filed. Shows assets, liabilities, credit lines. Check financials.**

AI Summary

Sabra Health Care REIT, Inc. filed its 10-Q for the period ending March 31, 2024. The company's financial statements indicate assets, liabilities, and equity, with specific line items such as Accounts Receivable, Prepaid Expenses, Deferred Financing Costs, and Other Assets Net. The filing also references their Line of Credit and Loans Payable to Bank, providing a snapshot of their financial position.

Why It Matters

This filing provides investors with an updated view of Sabra Health Care REIT's financial health and operational status for the first quarter of 2024, crucial for investment decisions.

Risk Assessment

Risk Level: medium — As a REIT, Sabra is subject to real estate market fluctuations, interest rate changes, and tenant financial health, which can impact its performance.

Key Numbers

Key Players & Entities

FAQ

What is the total revenue for Sabra Health Care REIT for the quarter ending March 31, 2024?

The provided header information does not contain specific revenue figures for the quarter ending March 31, 2024.

What are the company's outstanding debt obligations as of March 31, 2024?

The filing mentions 'Line of Credit' and 'Loans Payable to Bank' but does not specify the outstanding dollar amounts in the header.

Did Sabra Health Care REIT report any significant changes in its property portfolio during Q1 2024?

The provided header information does not detail changes in the company's property portfolio.

What is the net income or loss for Sabra Health Care REIT for the period ending March 31, 2024?

Specific net income or loss figures are not available in the header information of this filing.

Are there any new material contracts or agreements disclosed in this 10-Q?

The header information does not list details about new material contracts or agreements.

From the Filing

0001492298-24-000014.txt : 20240508 0001492298-24-000014.hdr.sgml : 20240508 20240508160744 ACCESSION NUMBER: 0001492298-24-000014 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 88 CONFORMED PERIOD OF REPORT: 20240331 FILED AS OF DATE: 20240508 DATE AS OF CHANGE: 20240508 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Sabra Health Care REIT, Inc. CENTRAL INDEX KEY: 0001492298 STANDARD INDUSTRIAL CLASSIFICATION: REAL ESTATE INVESTMENT TRUSTS [6798] ORGANIZATION NAME: 05 Real Estate & Construction IRS NUMBER: 272560479 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-34950 FILM NUMBER: 24925998 BUSINESS ADDRESS: STREET 1: 18500 VON KARMAN STREET 2: SUITE 550 CITY: IRVINE STATE: CA ZIP: 92612 BUSINESS PHONE: 888-393-8248 MAIL ADDRESS: STREET 1: 18500 VON KARMAN STREET 2: SUITE 550 CITY: IRVINE STATE: CA ZIP: 92612 10-Q 1 sbra-20240331.htm 10-Q sbra-20240331 0001492298 12/31 2024 Q1 false http://fasb.org/us-gaap/2023#HealthCareResidentServiceMember http://fasb.org/us-gaap/2023#HealthCareResidentServiceMember http://www.sabrahealth.com/20240331#AccountsReceivablePrepaidExpensesDeferredFinancingCostsAndOtherAssetsNet http://www.sabrahealth.com/20240331#AccountsReceivablePrepaidExpensesDeferredFinancingCostsAndOtherAssetsNet http://fasb.org/us-gaap/2023#AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent http://fasb.org/us-gaap/2023#AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent http://www.sabrahealth.com/20240331#AccountsReceivablePrepaidExpensesDeferredFinancingCostsAndOtherAssetsNet http://fasb.org/us-gaap/2023#AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent http://fasb.org/us-gaap/2023#LineOfCredit http://fasb.org/us-gaap/2023#LoansPayableToBank http://www.sabrahealth.com/20240331#AccountsReceivablePrepaidExpensesDeferredFinancingCostsAndOtherAssetsNet http://fasb.org/us-gaap/2023#AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent http://fasb.org/us-gaap/2023#LineOfCredit http://fasb.org/us-gaap/2023#LoansPayableToBank xbrli:shares iso4217:USD iso4217:USD xbrli:shares sbra:variableInterestEntity sbra:investment sbra:property sbra:facility sbra:bed xbrli:pure sbra:loan sbra:preferredEquityInvestment iso4217:CAD sbra:extensionOption sbra:derivative sbra:instrument 0001492298 2024-01-01 2024-03-31 0001492298 2024-05-01 0001492298 2024-03-31 0001492298 2023-12-31 0001492298 2023-01-01 2023-03-31 0001492298 sbra:TripleNetPortfolioMember 2024-01-01 2024-03-31 0001492298 sbra:TripleNetPortfolioMember 2023-01-01 2023-03-31 0001492298 sbra:SeniorHousingFacilitiesManagedPortfolioMember 2024-01-01 2024-03-31 0001492298 sbra:SeniorHousingFacilitiesManagedPortfolioMember 2023-01-01 2023-03-31 0001492298 us-gaap:CommonStockMember 2022-12-31 0001492298 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001492298 us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember 2022-12-31 0001492298 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001492298 2022-12-31 0001492298 us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember 2023-01-01 2023-03-31 0001492298 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-03-31 0001492298 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001492298 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001492298 us-gaap:CommonStockMember 2023-03-31 0001492298 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001492298 us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember 2023-03-31 0001492298 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-03-31 0001492298 2023-03-31 0001492298 us-gaap:CommonStockMember 2023-12-31 0001492298 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001492298 us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember 2023-12-31 0001492298 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001492298 us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember 2024-01-01 2024-03-31 0001492298 us-gaap:AccumulatedOtherComprehensiveInc

View on Read The Filing